Mendelian, a digital health startup from the UK, has just been awarded about €1.58 million (£1.4 million) to roll out its AI-based solution for rare disease diagnosis. It’s estimated that about 3.5 million people in the UK alone are living with a rare disease, and many of these might not be correctly diagnosed. In fact,…
This content is for members only. Visit the site and log in/register to read.
The post UK-based healthtech startup Mendelian receives €1.58 million to accelerate disease diagnosis appeared first on EU-Startups.